Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01902485 · ClinicalTrials.gov registry record · Phase 4
Study of Immediate Start of Progestin Contraceptives in Medical Abortion
A Phase 4 study of Contraception, sponsored by Gynuity Health Projects.
- Completed
- Registry status
- Phase 4
- Development phase
- 937
- Enrollment target
- 8
- Study locations
NCT01902485: Completed Phase 4 study of Contraception, sponsored by Gynuity Health Projects.
NCT01902485 is a Phase 4 study of Contraception that has completed, run by Gynuity Health Projects. The registered enrollment target is 937 participants, above the 442-participant average among 72 other Contraception trials with a reported enrollment target (112% higher). The trial reports 8 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01902485, a Phase 4 study of Contraception, has completed, sponsored by Gynuity Health Projects.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 937 participants
- Enrollment target
- 8
- Study locations
Study Summary
This study will compare immediate to post-abortion start of two progestin-based contraceptives (DMPA and etonorgestrel implants) among women having first trimester medical abortion who wish to use that method for post-abortion contraception.
Conditions Studied
Interventions
- OTHER Timing of Contraceptive Initiation in Medical Abortion
Study Locations (8)
California
- Planned Parenthood of the Pacific Southwest - Chula Vista
- Planned Parenthood Northern California - Eureka
Massachusetts
- Boston Medical Center - Boston
- Planned Parenthood League of Massachusetts - Boston
Other
- Centro de Salud Beatriz Velasco de Aleman - Mexico City
- Centro de Salud Santa Catarina - Mexico City
Connecticut
- Planned Parenthood of Southern New England - Stamford
Maryland
- Bayview Medical Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 937 participants |
| Start Date | 2013-07 |
| Est. Completion | 2015-12 |
| Phase | Phase 4 |
What the finished NCT01902485 record still lists
NCT01902485 is an interventional study that assigns participants to a tested intervention. The registered 937 participants enrollment target is mid-sized for trials with a published cap, above the 442-participant average among 72 other Contraception trials with a reported enrollment target (112% higher).
The record links to 1 condition, with Contraception appearing as the primary indexed condition, and to 1 intervention - of which Timing of Contraceptive Initiation in Medical Abortion is the first listed.
NCT01902485 lists 8 locations in 5 states (California, Massachusetts, Other).
Frequently Asked Questions
What is clinical trial NCT01902485 about?
NCT01902485 is a clinical study titled "Study of Immediate Start of Progestin Contraceptives in Medical Abortion". This study will compare immediate to post-abortion start of two progestin-based contraceptives (DMPA and etonorgestrel implants) among women having first trimester medical abortion who wish to use that method for post-abortion contraception.
What is the current status of trial NCT01902485?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 937 participants. The study started on 2013-07. Estimated completion is 2015-12.
What conditions does trial NCT01902485 study?
This clinical trial studies the following conditions: Contraception.
What interventions are being tested in trial NCT01902485?
The interventions under investigation include: Timing of Contraceptive Initiation in Medical Abortion (OTHER).
Who is sponsoring clinical trial NCT01902485?
This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01902485 being conducted?
This trial has 8 study locations across California, Connecticut, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01902485's enrollment target sits among peer trials
937 14th of 72 higher than 59 of 72 other Contraception trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Contraception trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Oral Contraceptive Pill (OCP) Pharmacogenomics
RECRUITING · Phase 4
-
Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement
RECRUITING · Phase 4
-
Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start
RECRUITING · Phase 4
-
Etonogestrel Implant as Emergency Contraception
RECRUITING · Phase 4
-
RCT Evaluating Standardized Counseling on Early Discontinuation for Irregular Bleeding in Nexplanon Users
ACTIVE NOT RECRUITING · Phase 4
-
Impact of Combined Hormonal Contraceptives on UPA
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05519007 · 936 participants · NA
Rate of Total Joint Infection 90-day After Surgery Following Irrigation With Next Science No-Rinse Solution vs SOC Alone
- NCT03075696 · 940 participants · Phase 1
A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma
- NCT06855277 · 940 participants · Phase 3
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- NCT04626635 · 933 participants · Phase 1
A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia